Table 3.

Summary of anti-HE4 antibodies and HE4 in serum and urine from patients with clinical evidence of stage III or IV OvC at the time of assay.

Patient	Anti-HE4 antibodies (mean OD) #		HE4 antigen (pM)
	Dilution 1:20	Dilution 1:100	Serum	Urine
1	0.63	0.57	439*	11.5*
2	0.29	0.18	180*	11.9*
3	0.03	0	116	7.0*
4	3.51*	3.65*	90	9.1*
5	1.70*	2.61*	652*	16.9*
6	0.01	0.09	665*	46.4*
7	0.10	0.21	492*	15.6*
8	0.30	0.16	71	1.5
9	0.65	0.39	73	2.2*
10	2.69*	1.38*	176*	8.1*
11	0.30	0.23	337*	4.9*
12	0	0	82	1.7
13	2.49*	2.93*	205*	2.2*

^#Cut-off values were the same as for the data presented in Table 2 and adsorption values corresponding to M+2 SD are indicated (*).

^##Sera were scored as positive for HE4 antigen using the 150 cutoff established for the FDI kit. Urine samples were assayed as described [42] and scored as positive (M+2SD) at a cut-off value of 2.0.